The insignificant difference in SMARCB1 expression in lung patients is consistent with previous studies that indicated that SMARCB1 mutation was frequently observed in pancreatic cancer, gastrointestinal cancer, and sinonasal carcinoma, but it was seldom recorded in lung carcinoma [32, 33]. Here, SMARCB1 is linked to nasal cavity and paranasal sinus carcinoma.